Key Takeaways
- • Healthcare private equity reached record deal value of $191 billion in 2025, surpassing the previous 2021 high, with 445 announced buyouts representing the second-highest annual transaction count on record.
- • Exit activity surged to $156 billion in 2025 from $54 billion in 2024, driven by sponsor-to-sponsor transactions—more than 30 deals exceeded $1 billion compared to only eight in 2024, signaling robust secondary market conditions.
- • Provider IT and technology-enabled assets drove 2025 growth, with healthcare IT deal value within the provider segment doubling to $32 billion, exemplified by Warburg Pincus's sale of ModMed to Clearlake Capital at a valuation exceeding $5 billion.
- • Middle-market healthcare financing requires specialized underwriting expertise in reimbursement timing, regulatory compliance, and industry-specific risk factors that generalist lenders lack, creating both complexity and opportunity for specialty credit providers.
- • PE investors increasingly target technology-enabled operational efficiency solutions, including revenue cycle management systems, workforce optimization platforms, and AI automation tools designed to enhance provider performance.
Summary
Healthcare private equity experienced exceptional growth in 2025, delivering record financial performance across both deal origination and exit activity. Disclosed deal value exceeded $191 billion, surpassing the previous record established in 2021, while transaction volume reached 445 announced buyouts—the second-highest annual total on record. This robust activity reflects sustained institutional capital deployment into the sector despite macroeconomic complexity.
Exit performance particularly distinguished 2025 results. Exit value rebounded sharply to $156 billion from $54 billion in 2024, driven predominantly by sponsor-to-sponsor transactions returning to market strength. More than 30 such transactions exceeded $1 billion in value compared to only eight transactions in that category during 2024, indicating accelerating secondary market liquidity and portfolio recycling among large PE sponsors.
Provider IT and technology-enabled assets anchored 2025's growth trajectory. Healthcare IT deal value within the provider segment doubled to an estimated $32 billion, reflecting PE investors' strategic pivot toward operational efficiency solutions. The segment's marquee transaction was Warburg Pincus's sale of its majority interest in ModMed, a provider IT platform, to Clearlake Capital at a valuation exceeding $5 billion. According to Bain & Company analysis, PE firms have sharpened focus on acquiring technology-enabled assets including analytics platforms, workforce optimization software, and AI automation tools designed to enhance provider operational performance and revenue cycle management.
Financing healthcare middle-market companies presents material complexity that distinguishes the sector from traditional industrial lending. The sector's unique characteristics—including reimbursement timing dynamics, regulatory scrutiny, and operational interdependencies—require specialized underwriting capabilities and deep sectoral expertise. Industry participants underscore that asset-based lending to healthcare represents a sophisticated specialty requiring substantial institutional knowledge; as one veteran noted, "detailed investigation of industry nuances and trends will reveal that asset-based lending to the healthcare industry is not an area to dabble in and definitely not for the faint of heart." This characterization highlights that specialty lenders capable of navigating healthcare-specific credit risks and operational metrics occupy distinct competitive positions within the private credit market.
Exit performance particularly distinguished 2025 results. Exit value rebounded sharply to $156 billion from $54 billion in 2024, driven predominantly by sponsor-to-sponsor transactions returning to market strength. More than 30 such transactions exceeded $1 billion in value compared to only eight transactions in that category during 2024, indicating accelerating secondary market liquidity and portfolio recycling among large PE sponsors.
Provider IT and technology-enabled assets anchored 2025's growth trajectory. Healthcare IT deal value within the provider segment doubled to an estimated $32 billion, reflecting PE investors' strategic pivot toward operational efficiency solutions. The segment's marquee transaction was Warburg Pincus's sale of its majority interest in ModMed, a provider IT platform, to Clearlake Capital at a valuation exceeding $5 billion. According to Bain & Company analysis, PE firms have sharpened focus on acquiring technology-enabled assets including analytics platforms, workforce optimization software, and AI automation tools designed to enhance provider operational performance and revenue cycle management.
Financing healthcare middle-market companies presents material complexity that distinguishes the sector from traditional industrial lending. The sector's unique characteristics—including reimbursement timing dynamics, regulatory scrutiny, and operational interdependencies—require specialized underwriting capabilities and deep sectoral expertise. Industry participants underscore that asset-based lending to healthcare represents a sophisticated specialty requiring substantial institutional knowledge; as one veteran noted, "detailed investigation of industry nuances and trends will reveal that asset-based lending to the healthcare industry is not an area to dabble in and definitely not for the faint of heart." This characterization highlights that specialty lenders capable of navigating healthcare-specific credit risks and operational metrics occupy distinct competitive positions within the private credit market.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.